These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24064185)

  • 1. Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in blood.
    Proitsi P; Lee SH; Lunnon K; Keohane A; Powell J; Troakes C; Al-Sarraj S; Furney S; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Hodges A;
    Neurobiol Aging; 2014 Feb; 35(2):279-90. PubMed ID: 24064185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures.
    Ma J; Zhang W; Tan L; Wang HF; Wan Y; Sun FR; Tan CC; Yu JT; Tan L; Alzheimer's Disease Neuroimaging Initiative
    Oncotarget; 2016 Sep; 7(37):58779-58788. PubMed ID: 27244883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
    Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
    J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease.
    Deng YL; Liu LH; Wang Y; Tang HD; Ren RJ; Xu W; Ma JF; Wang LL; Zhuang JP; Wang G; Chen SD
    Hum Genet; 2012 Jul; 131(7):1245-9. PubMed ID: 22382309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.
    Carrasquillo MM; Crook JE; Pedraza O; Thomas CS; Pankratz VS; Allen M; Nguyen T; Malphrus KG; Ma L; Bisceglio GD; Roberts RO; Lucas JA; Smith GE; Ivnik RJ; Machulda MM; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Neurobiol Aging; 2015 Jan; 36(1):60-7. PubMed ID: 25189118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer's disease.
    Mullan GM; McEneny J; Fuchs M; McMaster C; Todd S; McGuinness B; Henry M; Passmore AP; Young IS; Johnston JA
    Curr Alzheimer Res; 2013 Nov; 10(9):973-8. PubMed ID: 24117116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy.
    Ramirez LM; Goukasian N; Porat S; Hwang KS; Eastman JA; Hurtz S; Wang B; Vang N; Sears R; Klein E; Coppola G; Apostolova LG
    Neurobiol Aging; 2016 Mar; 39():82-9. PubMed ID: 26923404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease.
    Lacher SE; Alazizi A; Wang X; Bell DA; Pique-Regi R; Luca F; Slattery M
    Redox Biol; 2018 Apr; 14():686-693. PubMed ID: 29179108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
    Ma Y; Jun GR; Chung J; Zhang X; Kunkle BW; Naj AC; White CC; Bennett DA; De Jager PL; ; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg GD; Farrer LA; Lunetta KL
    Aging Cell; 2019 Aug; 18(4):e12964. PubMed ID: 31144443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
    Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
    BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
    Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
    PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels.
    Hou XH; Bi YL; Tan MS; Xu W; Li JQ; Shen XN; Dou KX; Tan CC; Tan L; ; Yu JT
    Neurobiol Aging; 2019 Dec; 84():241.e13-241.e20. PubMed ID: 31204042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment.
    Chico L; Simoncini C; Lo Gerfo A; Rocchi A; Petrozzi L; Carlesi C; Volpi L; Tognoni G; Siciliano G; Bonuccelli U
    Free Radic Res; 2013 Aug; 47(8):569-76. PubMed ID: 23668794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Alzheimer's genetic loci with mild behavioral impairment.
    Andrews SJ; Ismail Z; Anstey KJ; Mortby M
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):727-735. PubMed ID: 30378268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
    De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
    Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs.
    Katsumata Y; Nelson PT; Estus S; ; Fardo DW
    Neurobiol Aging; 2019 Feb; 74():135-146. PubMed ID: 30448613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.